Abstract
The development of induced pluripotent stem cells (iPSCs) has shown a great potential in disease modeling, drug screening, organ reconstruction and cancer therapy. Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), particularly in Western countries. However, HCV infection has never been fully understood because the culprit virus only preferably infects human and chimpanzee. Hepatocyte-like cells derived from human iPSCs have been reported to be susceptible to infection with HCV and may serve as an appropriate model for HCV infection. Recently, the field of HCV research has been revolutionized by the finding that pigtail macaque (Macaca nemestrina) hepatic cells derived from iPSCs support the entire HCV life cycle, and pigtail macaques may serve as a suitable, clinically relevant model for the study of HCV infection. Moreover, the technologies generating vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro have also been established. These findings will play a very important role in understanding the mechanism of HCV infection and therapy for HCV related HCC.
Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation.
Current Stem Cell Research & Therapy
Title:Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection
Volume: 10 Issue: 3
Author(s): Lin Cheng, Yong Zhang, Yuemin Nan and Liang Qiao
Affiliation:
Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation.
Abstract: The development of induced pluripotent stem cells (iPSCs) has shown a great potential in disease modeling, drug screening, organ reconstruction and cancer therapy. Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), particularly in Western countries. However, HCV infection has never been fully understood because the culprit virus only preferably infects human and chimpanzee. Hepatocyte-like cells derived from human iPSCs have been reported to be susceptible to infection with HCV and may serve as an appropriate model for HCV infection. Recently, the field of HCV research has been revolutionized by the finding that pigtail macaque (Macaca nemestrina) hepatic cells derived from iPSCs support the entire HCV life cycle, and pigtail macaques may serve as a suitable, clinically relevant model for the study of HCV infection. Moreover, the technologies generating vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro have also been established. These findings will play a very important role in understanding the mechanism of HCV infection and therapy for HCV related HCC.
Export Options
About this article
Cite this article as:
Cheng Lin, Zhang Yong, Nan Yuemin and Qiao Liang, Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection, Current Stem Cell Research & Therapy 2015; 10 (3) . https://dx.doi.org/10.2174/1574888X09666140923121234
DOI https://dx.doi.org/10.2174/1574888X09666140923121234 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design
Current Pharmaceutical Biotechnology Chlorambucil Cytotoxicity Reduction in Rats Through Bone Marrow, An In vivo Study
Anti-Cancer Agents in Medicinal Chemistry Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Haematopoietic Stem Cell Gene Therapy to Treat Autoimmune Disease
Current Stem Cell Research & Therapy Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection
Current Drug Metabolism Novel Rational Drug Design Strategies with Potential to Revolutionize Malaria Chemotherapy
Current Medicinal Chemistry Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Current Signal Transduction Therapy Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
Current Pharmaceutical Biotechnology Cyano Acrylate Polymers in Medical Applications
Recent Patents on Materials Science Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers Hybrid Compounds & Oxidative Stress Induced Apoptosis in Cancer Therapy
Current Medicinal Chemistry Cytochromes P450 in the Bioactivation of Chemicals
Current Topics in Medicinal Chemistry Signal Transduction Therapy with Rationally Designed Kinase Inhibitors
Current Signal Transduction Therapy Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy
Current Cancer Drug Targets The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications
Current Pharmaceutical Design Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science Therapeutic Potential of Herbal Molecules against Breast Cancer
Current Nutrition & Food Science